Regeneron Pharmaceuticals | REGN - Capitalização De Mercado

Preço das Ações
751.57
Mudança Diária
-14.45 -1.89%
Mensal
0.28%
Anual
24.71%
Q2 Previsão
735.49




Capitalização De Mercado Alterar Data
AbbVie USD 403.83B 5.2B 2025-12
Agenus USD 107M 16M 2025-12
Agios Pharmaceuticals USD 1.59B 745M 2025-12
Alnylam Pharmaceuticals USD 52.54B 7.24B 2025-12
Amgen USD 176.25B 24.32B 2025-12
AstraZeneca USD 288.15B 55.08B 2025-12
Biogen USD 25.82B 5.28B 2025-12
BioMarin Pharmaceutical USD 11.42B 1.02B 2025-12
Bristol-Myers Squibb USD 109.81B 18.01B 2025-12
Eli Lilly USD 1.02T 293.84B 2025-12
Esperion Therapeutics USD 885M 351M 2025-12
Gilead Sciences USD 166.62B 14.34B 2026-04
GlaxoSmithKline GBP 74.36B 10.31B 2025-12
Incyte USD 19.39B 2.83B 2025-12
Ionis Pharmaceuticals USD 12.81B 2.39B 2025-12
J&J USD 561.65B 17.5B 2026-04
Kyowa Hakko Kirin JPY 1.33T 120.11B 2025-12
Merck USD 261.26B 51.62B 2025-12
Neurocrine Biosciences USD 14.14B 218M 2025-12
Novartis USD 292.21B 26.55B 2025-12
Novartis USD 263.08B 17.01B 2025-12
Pfizer USD 141.57B 6.48B 2025-12
Regeneron Pharmaceuticals USD 81.12B 21.53B 2025-12
Roche Holding CHF 266.34B 55.46B 2025-12
Sanofi EUR 117.34B 2.45B 2025-12
Sarepta Therapeutics USD 2.26B 238M 2025-12
Teva Pharmaceutical Industries USD 36.42B 14.06B 2025-12
Ultragenyx Pharmaceutical USD 2.22B 680M 2025-12
United Therapeutics USD 20.98B 2.02B 2025-12
Vertex Pharmaceuticals USD 115.03B 14.61B 2025-12